Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07650708 · ClinicalTrials.gov registry record · Phase 4

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

A Phase 4 study, sponsored by Vance Thompson Vision.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target

NCT07650708: Recruiting Phase 4 study, sponsored by Vance Thompson Vision.

NCT07650708 is a Phase 4 study that is actively recruiting participants, run by Vance Thompson Vision. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07650708, a Phase 4 study, is actively recruiting participants, sponsored by Vance Thompson Vision.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

Primary Outcome

Visual analog scole with a minimum score of 0 (lowest rating) and maximum score of 100 (highest rating)

Interventions

  • DRUG Miebo four times per day

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-05-05
Est. Completion 2026-12-01
Phase Phase 4
Vance Thompson Vision

14 total trials

What NCT07650708 shows while recruiting

NCT07650708 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Miebo four times per day is the first listed.

NCT07650708 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07650708 about?

NCT07650708 is a clinical study titled "A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK". Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

What is the current status of trial NCT07650708?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2026-05-05. Estimated completion is 2026-12-01.

What interventions are being tested in trial NCT07650708?

The interventions under investigation include: Miebo four times per day (DRUG).

Who is sponsoring clinical trial NCT07650708?

This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07650708's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07650708, the US trial registry maintained by the National Library of Medicine. NCT07650708 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.